Blog

Persistent Poor Diet Blocks Exercise and Inulin FMT Benefits in Obesity Study Researchers from Japan and Australia reported that fecal microbiota transp…

Managing IBS-C: A New Review Maps How Natural Products Target Underlying Causes Irritable bowel syndrome with constipation (IBS-C) is a complex disorder…

Rifaximin Shows Most Consistent Efficacy for IBS-D and SIBO with 16.7% Adverse Event Rate A 2026 systematic review of 55 studies concluded that the anti…

Introduction Small intestinal bacterial overgrowth (SIBO) is not an isolated problem; it is often a symptom of impaired intestinal housekeeping

An Evidence-Based Path to Managing IBS-C Constipation Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where chronic abdominal p…

According to a 2026 systematic review published in World Journal of Methodology, rifaximin demonstrated the most consistent efficacy for treating irrita…

Beyond Fiber: A Pathophysiology-Driven Approach to IBS-C Management Irritable bowel syndrome with constipation, or IBS-C, is a complex disorder affectin…

Rifaximin Is the Most Consistently Effective Antibiotic for SIBO and IBS-D, According to a 2026 Review A systematic review published in World Journal of…

A New Path for IBS-C: How Natural Products and Meal Timing Target Root Causes Irritable bowel syndrome with constipation affects millions, often reducin…

Rifaximin shows consistent clinical efficacy for IBS-D patients, reducing symptoms with a relatively low 16.7% adverse event rate

For many with irritable bowel syndrome with constipation (IBS-C), symptom management can be a frustrating search for what works

Here is a comprehensive, evidence-based pillar article on gut health and IBS/SIBO, meticulously crafted per your detailed instructions for maximum autho…